Copyright © 2019 IPWatchdog, Inc.  Contact Us

Drafting at the Life Sciences/AI Interface

Determining whether to patent an AI-implemented invention, especially one embodying a life science related innovation or technology, is a difficult assessment. And drafting a related patent application is also extremely difficult given the complexity of the law, the abhorrence of abstractness and the very nature that AI on some level must be abstract to be useful.

In this webinar, we will review current approaches for deciding whether to patent an AI-implemented biotechnology, pharmaceutical, or medical device invention, or whether the best course of action is to keep the innovation as a trade secret.

Join Gene Quinn, President & CEO of IPWatchdog, Inc., on Wednesday, January 22, 2020 at 12pm ET as he moderates a wide-ranging discussion on the intersection of artificial intelligence and life sciences. Joining Gene will be Bruce Wu, Director of Global IP for Illumina, Kevin Buckley, Founder of Torrey Pines Law Group, Neil Thompson, Patent Agent at Torrey Pines Law Group, and Steve Walsh, Senior Manager for Business Development at Morningside IP.

In addition to taking as many questions as possible, we will also discuss:

Please Note: Your registration information will be shared with the sponsor and speakers of this webinar.

We record all of our webinars, and previously aired webinars and their slide decks, are then made available on our Past Webinars Page on IPWatchdog.  
Not a Problem!
New webinars are usually added within 24-48 hours after they have aired. 
View This Webinar

 This Webinar was previously held on 

WEDNESDAY, January 22, 2020

About This Webinar:

Webinar  Sponsored By:

Did you miss this Webinar?
View This Webinar

Our Speakers

Webinar Sponsored By:

BRUCE WU is is a Director, Global Intellectual Property at Illumina.  He currently leads Illumina's global IP strategy in sequencing platform and engineering related technologies.  Prior to Illumina, he was an in-house counsel at HP Inc., managing several of HP's patent portfolios.  Bruce received a JD from Georgetown, and a PhD and a MS both in engineering from MIT.  One of his interest is building IP portfolios creatively and holistically by finding synergy between law and the different disciplines of science.

Kevin Buckley

Founder, Torrey

Pines Law Group

Bruce Wu 

Director, Global IP

Illumina

GENE QUINN is a US Patent Attorney, the founder of IPWatchdog.com and a Top 300 IP Strategist.  Gene writes about patent law, patent and innovation policy, proposed legislation, rulemaking, software patents and more. In 2014, Mr. Quinn was named one of the top 50 most influential people in IP by Managing IP Magazine. And in both 2017 and 2018, he has been recognized by IAM Magazine as one of the top IP strategists in the world. Regarded as an expert on software patentability and U.S. patent procedure, Mr. Quinn regularly advises attorneys and clients on patent matters, litigation strategy and appeals. 

Morningside IP is a recognized leader in global patent filing and one of the largest intellectual property translation companies in the world. With a single instruction, Morningside can prepare high-quality patent translations and file applications in over 150 jurisdictions. Find out why over 1/3 of the Top 100 PCT filers in North America rely on Morningside for their patent translation & foreign filing needs.

Torrey Pines Law Group was founded in 2013 by Kevin Buckley -- an accomplished patent attorney having 20 years of experience with international intellectual property, technology commercialization, and litigation matters. Kevin practiced in a prominent international law firm before founding TPLG where he handled complex legal matters for companies researching and developing biotechnologies, pharmaceuticals, medical devices, and convergence technologies. Torrey Pines Law Group combines the expertise and quality of a large firm, with the value and personalized service of a small firm.

Neil Thompson

Patent Agent,Torrey 

Pines Law Group

  • Best practices for preparing AI-implemented life sciences applications, including how the invention should be claimed and the specification structured.
  • How to prepare your specification and drawings to ensure that an invention’s elements are effectively translated internationally.
  • Tips and Tricks for getting to a faster, more economical result when using the European Patent Office (EPO) for software related patent applications.

Gene Quinn 

IPWatchdog Founder,

Top 300 Strategist

Steve Walsh 

Regional IP Manager

Morningside IP

KEVIN BUCKLEY is the founder of Torrey Pines Law Group and has been working with inventions at the AI/Life Sciences interface since 2013. Kevin was also Chief IP Counsel for a company that obtained the first FDA clearance for an AI-enabled breast cancer detection system. He has more than 20 years of experience as a patent attorney assisting biotech, pharmaceutical, and medical device clients with IP, transactional, and regulatory matters.

NEIL THOMPSON is a patent agent at Torrey Pines Law Group. For several years, he worked as a product development engineer in the medical device industry. At Torrey Pines, he is the resident expert on patent applications related to medical devices.

STEVE WALSH is a Senior Manager of Business Development specializing in patent litigation language solutions. With over 10 years’ of experience, Steve has worked on some of the largest global IP matters involving biotechnology and medical devices for cases tried at the ITC, Federal Court Circuit and the PTAB.